Use of gene-modified regulatory T-cells to control autoimmune and alloimmune pathology: is now the right time?
Clin Immunol
; 150(1): 51-63, 2014 Jan.
Article
em En
| MEDLINE
| ID: mdl-24333533
Palavras-chave
CAR; CEA; CNS; Chimeric antigen receptor; FoxP3; GITR; Gene therapy; GvHD; Immunotherapy; LTR; MAGE; MOG; RRE; Regulatory T-cell; Rev response element; T-cell receptor; T1DM; TGF-ß; carcinoembryonic antigen; central nervous system; chimeric antigen receptor; glucocorticoid-induced TNFR-related protein; graft versus host disease; long terminal repeat; melanoma-associated antigen; myelin oligodendrocyte glycoprotein; tTreg; thymic regulatory T-cell; transforming growth factor-ß; type 1 diabetes
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Imunoterapia Adotiva
/
Linfócitos T Reguladores
Tipo de estudo:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Animals
/
Humans
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article